Stay updated on Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 on the page. This reflects a newer build of the site rather than changes to the study content.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page’s footer indicates the ClinicalTrials.gov interface was revised from v3.5.2 to v3.5.3. This reflects a site/version update rather than a change to the study record itself.SummaryDifference0.0%

- Check37 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-facing content changes are indicated.SummaryDifference0.0%

- Check66 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision history updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

- Check102 days agoChange DetectedAn administrative site update adds Revision: v3.4.2, and a government funding status notice was removed (Revision: v3.4.1). These changes do not affect study details, eligibility criteria, or results on the page.SummaryDifference0.4%

Stay in the know with updates to Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Degludec vs Glargine U100 in Type 2 Diabetes Clinical Trial page.